Diagnostic Value of Contrast-Enhanced Fluid-Attenuated Inversion-Recovery and Delayed Contrast-Enhanced Brain MRI in Multiple Sclerosis

2008 ◽  
Vol 15 (1) ◽  
pp. 15-23 ◽  
Author(s):  
Mohammad Hadi Bagheri ◽  
Arash Meshksar ◽  
Seyyed Ali Nabavizadeh ◽  
Afshin Borhani-Haghighi ◽  
Nahid Ashjazadeh ◽  
...  
2021 ◽  
Vol 20 (1) ◽  
pp. 35-40
Author(s):  
Mehran Yousefi ◽  
◽  
Mehdi Panahali ◽  
Kamran Azarkhish ◽  
Nazanin Azizi Shalbaf ◽  
...  

Background. The 2010 revision of the McDonald criteria, widely used for the diagnosis of multiple sclerosis (MS), has established that dissemination in time (DIT) can be demonstrated by the simultaneous presence of asymptomatic gadolinium-enhancing and non-enhancing plaques on a single magnetic resonance imaging (MRI). When the use of gadolinium contrast agents is contraindicated, diffusion-weighted imaging (DWI) is utilized to confirm diffusion alterations in active inflammatory plaques. This study intended to examine whether DWI can be a viable alternative to contrast-enhanced T1-weighted imaging for demonstrating DIT in MS. Material and methods.We assessed 30 previously diagnosed MS patients during acute relapse (based on the 2010 McDonald criteria) and evaluated their brain MRI via DWI‚ contrast-enhanced T1-weighted imaging, and FLAIR sequences. Asymptomatic plaques were defined as either hyperintense or non-hyperintense in DWI and enhancing or non-enhancing in T1GAD-MRI. Statistical indices for the prediction of plaque enhancement in T1 GAD-MRI via DWI-MRI were calculated and compared. Results. The 30 participants in our study had a total of 925 demyelinating plaques that were larger than 3mm in size and presented to be hyperintense in FLAIR-MRI. Diffusion hyperintensity and plaque enhancement were significantly correlated. The sensitivity‚ specificity, positive predictive value‚ negative predictive value, and accuracy of DWI were calculated to be 69.66%‚ 99.76%‚ 96.88%‚ 96.86%, and 96.86%, respectively. Conclusions. Hyperintense DWI findings do not necessarily overlap with contrast enhancements in T1 GAD-MRI. DWI was shown to produce a higher rate of false-positive results. Our study concludes that although T1 GAD-MRI should not be replaced by DWI to determine DIT due to its lower specificity, DWI’s continued use as a surrogate screening imaging sequence whenever the use of T1GAD-MRI is of concern is not without its merits.


2015 ◽  
Vol 56 (5) ◽  
pp. 622-627 ◽  
Author(s):  
Carolin Gramsch ◽  
Felix Nensa ◽  
Oliver Kastrup ◽  
Stefan Maderwald ◽  
Cornelius Deuschl ◽  
...  

2018 ◽  
Vol 5 (5) ◽  
pp. e480 ◽  
Author(s):  
Kianush Karimian-Jazi ◽  
Brigitte Wildemann ◽  
Ricarda Diem ◽  
Daniel Schwarz ◽  
Thomas Hielscher ◽  
...  

ObjectiveTo assess the diagnostic value of gadolinium (Gd) contrast administration in MRI follow-up examinations of patients with MS if the T2 lesion load is stable.MethodsWe included 100 patients with MS with at least 2 cranial MRI follow-up examinations (mean follow-up time 4.0 ± 2.6 years). MRI was performed at 3 Tesla with a standardized protocol including T2-weighted, fluid-attenuated inversion recovery (FLAIR) and T1-weighted contrast-enhanced sequences. Images were analyzed for T2/FLAIR and contrast-enhancing (CE) lesions by 3 independent neuroradiologists. Isolated Gd-enhancing lesions without correlate in T2 and FLAIR images, and reactivated Gd+ lesions were further assessed for size and signal intensity.ResultsWe identified a total of 343 new T2 lesions and 152 CE lesions in a total of 559 MRI follow-up examinations. New T2/FLAIR lesions were present in 30% of the scans. Of the Gd-enhancing lesions, 145/152 (95.4%) showed a correlate as a new T2/FLAIR lesion. There were 3 enhancing lesions (1.9% of all enhancing lesions) without T2/FLAIR correlate and 4 lesions (2.6%) that exhibited lesion reactivation or persistent enhancement over time. As a predictive factor of enhancement, we found that enhancing lesions had a higher T2 signal ratio (T2 SRlesion/normal-appearing white matter: 3.0 ± 0.1 vs 2.2 ± 0.1, p < 0.001).ConclusionThe likelihood of missing “active lesions” is overall small (1.7%) if T2 lesions are stable compared with the previous MRI examination. Lesion reactivation is rare. Our study indicates that Gd contrast administration might be dispensable in follow-up MRI of patients with MS if no new T2/FLAIR lesions and no new neurologic symptoms are present.


2000 ◽  
Vol 43 (3) ◽  
pp. 257
Author(s):  
Chan Kyo Kim ◽  
Dong Gyu Na ◽  
Wook Jae Ryoo ◽  
Hong Sik Byun ◽  
Hye Kyung Yoon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document